




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Fitzpatrick	(2017)	 USA	 Depression		 70	[34 36]	 22.2	(2.33)	 Woebot	 CBT	 Psychoeducation			
2	weeks	
20	sessions	 PHQ 9		 17.1%	 	
Flett	(2019)		 New	Zealand	 Depression		
210	[72 73]	























Franklin	(2016)	 	Study	2	 131	[62 69]	 22.9	(5.0)	 9.1%	 	
Franklin	(2016)	 	Study	3	 163	[78 85]	 24.5	(6.6)	 15.5%	 	
Hur	(2018)	 Korea	 Depression	 48	[24 24]	 23.7	(3.3)	 Todac	Todac	 CBT	 Daily	mood	chart	 3	weeks	3	sessions	daily		 BDI II		 20.8%	 	








2	entries	per	day		 DASS D	 14.9%	
6	
weeks	
Lee	(2018)	 Canada	 Depression	 163	[77 86]	 20.6	( )	 DeStressify	 Mindfulness	 Wait list		 4	weeks		5	days	per	week	 QIDS SR			 20.8%	 	
Levin	(2020)	 USA	 Depression	 23	[10 13]	 20.4	(2.5)	 Stop,	Breathe		and	Think	 Mindfulness	 Wait list	 4	weeks	 CCAPS 34	 30.4%	 	





5	days	per	week	 HDRS			 23.9%	 	
Tighe	(2017)	 Australia	 Suicidal	ideation		&	depression	 61	[31 30]	 26.3	(8.1)	 iBobbly	 ACT	 Wait list		 6	weeks	
DSI SS	
PHQ 9		 3.2%	 	
	
Abbrev at ons:	Tota 	N:	Number	of	part c pants	a ocated	to	groups	at	base ne,	 :	 ntervent on	group,	C:	contro 	group,	C T:	Cogn t ve	 ehav oura 	Therapy;	ACT:	Acceptance	Comm tment	Therapy;	P Q-9:	Pat ent	 ea th	Quest onna re-9;	CES-D:	Centre	
for	Ep dem o og c	Stud es	Depress on	Sca e;	 D - :	 eck	Depress on	 nventory- ;	DASS-D:	Depress on	Anx ety	Stress	Sca es	–	Depress on	Subsca e;	Q DS-SR:	The	Qu ck	 nventory	of	Depress ve	Symptomo ogy-	Se f	Report;	CCAPS-D:	Counse ng	Centre	










































































































































































































































Editorials	 		 N/A	 1,000	
Essays	 		 250	 N/A	
Commentaries	 		 250	 800	
Brief	Communications	 		 250	 1,500	
*	Excludes	references,	tables	and	legends	
3.3	Writing	your	paper	
The	SAGE	Author	Gateway	has	some	general	advice	and	on	how	to	get	published,	plus	
links	to	further	resources.	
3.3.1	Making	your	article	discoverable	
When	writing	up	your	paper,	think	about	how	you	can	make	it	discoverable.	The	title,	
keywords	and	abstract	are	key	to	ensuring	readers	find	your	article	through	search	
engines	such	as	Google.	For	information	and	guidance	on	how	best	to	title	your	article,	
write	your	abstract	and	select	your	keywords,	have	a	look	at	this	page	on	the	
Gateway:	How	to	Help	Readers	Find	Your	Article	Online.	
Back	to	top	
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4.	Peer	review	policy	
Following	a	preliminary	triage	to	eliminate	submissions	unsuitable	for	DIGITAL	
HEALTH	all	papers	are	sent	out	for	review.	The	covering	letter	is	important.	To	help	the	
Editor	in	his	preliminary	evaluation,	please	indicate	why	you	think	the	paper	suitable	
for	publication.	If	your	paper	should	be	considered	for	fast-track	publication,	please	
explain	why.	
The	journal’s	policy	is	to	have	manuscripts	reviewed	by	two	expert	reviewers.	DIGITAL	
HEALTH	utilizes	a	single-blind	peer	review	process	in	which	the	reviewer’s	name	and	
information	is	withheld	from	the	author.	All	manuscripts	are	reviewed	as	rapidly	as	
possible,	while	maintaining	rigor.	Reviewers	make	comments	to	the	author	and	
recommendations	to	the	relevant	Editor-in-Chief	who	then	makes	the	final	decision.	
As	part	of	the	submission	process	you	will	be	asked	to	provide	the	names	of	peers	who	
could	be	called	upon	to	review	your	manuscript.	Recommended	reviewers	should	be	
experts	in	their	fields	and	should	be	able	to	provide	an	objective	assessment	of	the	
manuscript.	Please	be	aware	of	any	conflicts	of	interest	when	recommending	reviewers.	
Examples	of	conflicts	of	interest	include	(but	are	not	limited	to)	the	below:		
• 	
o The	reviewer	should	have	no	prior	knowledge	of	your	submission	
o The	reviewer	should	not	have	recently	collaborated	with	any	of	the	
authors	
o Reviewer	nominees	from	the	same	institution	as	any	of	the	authors	are	
not	permitted	
You	will	also	be	asked	to	nominate	peers	who	you	do	not	wish	to	review	your	
manuscript	(opposed	reviewers).	
Please	note	that	the	Editors	are	not	obliged	to	invite	any	recommended/opposed	
reviewers	to	assess	your	manuscript.	
The	Editor	or	members	of	the	Editorial	Board	may	occasionally	submit	their	own	
manuscripts	for	possible	publication	in	the	journal.	In	these	cases,	the	peer	review	
process	will	be	managed	by	alternative	members	of	the	Board	and	the	submitting	Editor	
/	Board	member	will	have	no	involvement	in	the	decision-making	process.	
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DIGITAL	HEALTH	is	committed	to	delivering	high	quality,	fast	peer-review	for	your	
paper,	and	as	such	has	partnered	with	Publons.	Publons	is	a	third	party	service	that	
seeks	to	track,	verify	and	give	credit	for	peer	review.	Reviewers	for	DIGITAL	
HEALTH	can	opt	in	to	Publons	in	order	to	claim	their	reviews	or	have	them	
automatically	verified	and	added	to	their	reviewer	profile.	Reviewers	claiming	credit	for	
their	review	will	be	associated	with	the	relevant	journal,	but	the	article	name,	
reviewer’s	decision	and	the	content	of	their	review	is	not	published	on	the	site.	For	
more	information	visit	the	Publons	website.		
Back	to	top	
5.	Editorial	policies	
At	the	end	of	your	article	the	following	declaration	statements	should	be	included	in	the	
order	listed	below:	
DECLARATIONS	
Conflicting	interests	
Funding		
Ethical	approval	
Guarantor		
Contributorship	
Acknowledgements	
Please	see	the	below	example	of	a	completed	declarations	section:	
DECLARATIONS	
Conflicting	interests:	MS	is	an	employee	of	XXX.	BF	has	received	grants	from	XXX.		
Funding:	This	work	was	supported	by	the	Medical	Research	Council	[grant	number	
XXX].	
Ethical	approval:	The	ethics	committee	of		XXXX	approved	this	study	(REC	number:	
XXXX)	
Guarantor:	BF	
Contributorship:	BF	and	NP	researched	literature	and	conceived	the	study.	MS	was	
involved	in	protocol	development,	gaining	ethical	approval,	patient	recruitment	and	
data	analysis.	BF	wrote	the	first	draft	of	the	manuscript.	All	authors	reviewed	and	
edited	the	manuscript	and	approved	the	final	version	of	the	manuscript	
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Acknowledgements:	We	would	like	to	thank	XXX	XXXX	for	his	assistance	and	guidance	
in	this	research.	
Please	read	the	following	information	carefully	for	additional	information	regarding	
these	declarations.	
Back	to	top	
5.1	Declaration	of	conflicting	interests	
It	is	the	policy	of	DIGITAL	HEALTH	to	require	a	declaration	of	conflicting	interests	from	
all	authors	enabling	a	statement	to	be	carried	within	the	paginated	pages	of	all	
published	articles.	
Please	ensure	that	a	‘Declaration	of	Conflicting	Interests’	statement	is	included	at	the	
end	of	your	manuscript,	after	any	acknowledgements	and	prior	to	the	references.	If	no	
conflict	exists,	please	state	that	‘The	Author(s)	declare(s)	that	there	is	no	conflict	of	
interest’.	
For	guidance	on	conflict	of	interest	statements,	please	see	the	ICMJE	recommendations.	
When	making	a	declaration	the	disclosure	information	must	be	specific	and	include	any	
financial	relationship	that	any	of	the	authors	of	the	article	have	with	any	sponsoring	
organization	and	the	for-profit	interests	the	organization	represents,	and	with	any	for-
profit	product	discussed	or	implied	in	the	text	of	the	article.	
Any	commercial	or	financial	involvements	that	might	represent	an	appearance	of	a	
conflict	of	interest	need	to	be	additionally	disclosed	in	the	covering	letter	accompanying	
your	article	to	assist	the	Editors-in-Chief	in	evaluating	whether	sufficient	disclosure	has	
been	made	within	the	Declaration	of	Conflicting	Interests	provided	in	the	article.	
For	more	information	please	visit	the	SAGE	Journal	Author	Gateway.	
5.2	Funding	
DIGITAL	HEALTH	requires	all	authors	to	acknowledge	their	funding	in	a	consistent	
fashion	under	a	separate	heading.		Please	visit	the	Funding	Acknowledgements	page	on	
the	SAGE	Journal	Author	Gateway	to	confirm	the	format	of	the	acknowledgment	text	in	
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the	event	of	funding,	or	state	that:	“This	research	received	no	specific	grant	from	any	
funding	agency	in	the	public,	commercial,	or	not-for-profit	sectors.”		
5.3	Research	ethics	and	patient	consent	
Medical	research	involving	human	subjects	must	be	conducted	according	to	the	World	
Medical	Association	Declaration	of	Helsinki.	
Submitted	manuscripts	should	conform	to	the	ICMJE	Recommendations	for	the	
Conduct,	Reporting,	Editing,	and	Publication	of	Scholarly	Work	in	Medical	Journals,	and	
all	papers	reporting	animal	and/or	human	studies	must	state	in	the	methods	section	
that	the	relevant	Ethics	Committee	or	Institutional	Review	Board	provided	(or	waived)	
approval.	Please	ensure	that	you	have	provided	the	full	name	and	institution	of	the	
review	committee,	in	addition	to	the	approval	number.	
For	research	articles,	authors	are	also	required	to	state	in	the	methods	section	whether	
participants	provided	informed	consent	for	participation	in	the	study	and	whether	the	
consent	was	written	or	verbal.	
Information	on	informed	patient	consent	to	report	individual	cases	or	case	series	
should	be	also	included	in	the	manuscript	text	where	relevant.	A	statement	is	required	
regarding	whether	written	informed	consent	for	patient	information	and	images	to	be	
published	was	provided	by	the	patient(s)	or	a	legally	authorized	representative.	
Identifying	information,	including	patients'	names,	initials,	or	hospital	numbers,	should	
not	be	published	in	written	descriptions,	photographs,	and	pedigrees	unless	the	
information	is	essential	for	scientific	purposes	and	the	patient	(or	parent	or	guardian)	
gives	written	informed	consent	for	publication.	Informed	consent	for	this	purpose	
requires	that	a	patient	who	is	identifiable	be	shown	the	manuscript	to	be	published.	
Identifying	details	should	be	omitted	if	they	are	not	essential.	Complete	anonymity	is	
difficult	to	achieve,	however,	and	informed	consent	should	be	obtained	if	there	is	any	
doubt.	For	example,	masking	the	eye	region	in	photographs	of	patients	is	inadequate	
protection	of	anonymity.	If	identifying	characteristics	are	altered	to	protect	anonymity,	
such	as	in	genetic	pedigrees,	authors	should	provide	assurance	that	alterations	do	not	
distort	scientific	meaning	and	Editors	should	so	note.	
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Please	also	refer	to	the	ICMJE	Recommendations	for	the	Protection	of	Research	
Participants.	
All	research	involving	animals	submitted	for	publication	must	be	approved	by	an	ethics	
committee	with	oversight	of	the	facility	in	which	the	studies	were	conducted.	The	
journal	has	adopted	the	Consensus	Author	Guidelines	on	Animal	Ethics	and	Welfare	for	
Veterinary	Journals	published	by	the	International	Association	of	Veterinary	Editors.	
When	reporting	experiments	on	animals,	indicate	within	the	Methods	section	which	
guideline/law	on	the	care	and	use	of	laboratory	animals	was	followed.	
5.4	Clinical	trials	and	CONSORT	
DIGITAL	HEALTH	conforms	to	the	ICMJE	requirement	that	clinical	trials	are	registered	
in	a	WHO-approved	public	trials	registry	at	or	before	the	time	of	first	patient	enrolment	
as	a	condition	of	consideration	for	publication.	The	trial	registry	name	and	URL,	and	
registration	number	must	be	included	at	the	end	of	the	abstract.	For	this	purpose,	a	
clinical	trial	is	defined	as	any	research	project	that	prospectively	assigns	human	
subjects	to	intervention	or	comparison	groups	to	study	the	cause-and-effect	
relationship	between	a	medical	intervention	and	a	health	outcome.	Studies	designed	for	
other	purposes,	such	as	to	study	pharmacokinetics	or	major	toxicity	(e.g.	phase	I	trials),	
would	be	exempt.	Further	information	can	be	found	at	www.icmje.org	.	
All	randomized	controlled	trials	submitted	for	publication	should	include	a	completed	
Consolidated	Standards	of	Reporting	Trials	(CONSORT)	flow	chart.	Please	refer	to	the	
CONSORT	statement	website	at	http://www.consort-statement.org	for	more	
information.	
5.5	Reporting	guidelines	
The	relevant	EQUATOR	Network	reporting	guidelines	should	be	followed	depending	on	
the	type	of	study.	For	example,	all	randomized	controlled	trials	submitted	for	
publication	should	include	a	completed	CONSORT	flow	chart	as	a	cited	figure	and	the	
completed	CONSORT	checklist	should	be	uploaded	with	your	submission	as	a	
supplementary	file.	Systematic	reviews	and	meta-analyses	should	include	the	
completed	PRISMA	flow	chart	as	a	cited	figure	and	the	completed	PRISMA	checklist	
should	be	uploaded	with	your	submission	as	a	supplementary	file.	The	EQUATOR	
wizard	can	help	you	identify	the	appropriate	guideline.	
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Other	resources	can	be	found	at	NLM’s	Research	Reporting	Guidelines	and	Initiatives.	
5.6	Guarantor	
The	Guarantor	is	the	person	willing	to	take	full	responsibility	for	the	article,	including	
for	the	accuracy	and	appropriateness	of	the	reference	list.	This	will	often	be	the	most	
senior	member	of	the	research	group	and	is	commonly	also	the	author	for	
correspondence.	Please	state	this	person’s	name	as	initials.	
5.7	Authorship	
Papers	should	only	be	submitted	for	consideration	once	consent	is	given	by	all	
contributing	authors.	Those	submitting	papers	should	carefully	check	that	all	those	
whose	work	contributed	to	the	paper	are	acknowledged	as	contributing	authors.	
The	list	of	authors	should	include	all	those	who	can	legitimately	claim	authorship.	This	
is	all	those	who:	
1. 	
1. Made	a	substantial	contribution	to	the	concept	or	design	of	the	work;	or	
acquisition,	analysis	or	interpretation	of	data,	
2. Drafted	the	article	or	revised	it	critically	for	important	intellectual	
content,	
3. Approved	the	version	to	be	published,	
4. Each	author	should	have	participated	sufficiently	in	the	work	to	take	
public	responsibility	for	appropriate	portions	of	the	content.	
Authors	should	meet	the	conditions	of	all	of	the	points	above.	Each	author	should	have	
participated	sufficiently	in	the	work	to	take	public	responsibility	for	appropriate	
portions	of	the	content.	
When	a	large,	multicentre	group	has	conducted	the	work,	the	group	should	identify	the	
individuals	who	accept	direct	responsibility	for	the	manuscript.	These	individuals	
should	fully	meet	the	criteria	for	authorship.	
Acquisition	of	funding,	collection	of	data,	or	general	supervision	of	the	research	group	
alone	does	not	constitute	authorship,	although	all	contributors	who	do	not	meet	the	
criteria	for	authorship	should	be	listed	in	the	Acknowledgments	section.	Please	refer	to	
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the	International	Committee	of	Medical	Journal	Editors	(ICMJE)	authorship	
guidelines	for	more	information	on	authorship.	
5.8	Acknowledgements	
All	contributors	who	do	not	meet	the	criteria	for	authorship	should	be	listed	in	an	
Acknowledgements	section.	Examples	of	those	who	might	be	acknowledged	include	a	
person	who	provided	purely	technical	help,	or	a	department	chair	who	provided	only	
general	support.	
5.8.1	Third	party	submissions	
Where	an	individual	who	is	not	listed	as	an	author	submits	a	manuscript	on	behalf	of	
the	author(s),	a	statement	must	be	included	in	the	Acknowledgements	section	of	the	
manuscript	and	in	the	accompanying	cover	letter.	The	statements	must:	
•				Disclose	this	type	of	editorial	assistance	 	including	the	individual’s	name,	
company	and	level	of	input		
•				Identify	any	entities	that	paid	for	this	assistance		
•				Confirm	that	the	listed	authors	have	authorized	the	submission	of	their	
manuscript	via	third	party	and	approved	any	statements	or	declarations,	e.g.	
conflicting	interests,	funding,	etc.	
Where	appropriate,	SAGE	reserves	the	right	to	deny	consideration	to	manuscripts	
submitted	by	a	third	party	rather	than	by	the	authors	themselves.	
5.8.2	Writing	assistance	
Individuals	who	provided	writing	assistance,	e.g.	from	a	specialist	communications	
company,	do	not	qualify	as	authors	and	so	should	be	included	in	the	Acknowledgements	
section.	Authors	must	disclose	any	writing	assistance	 	including	the	individual’s	name,	
company	and	level	of	input	 	and	identify	the	entity	that	paid	for	this	assistance.	
It	is	not	necessary	to	disclose	use	of	language	polishing	services.	
Any	acknowledgements	should	appear	first	at	the	end	of	your	article	prior	to	your	
Declaration	of	Conflicting	Interests	(if	applicable),	any	notes	and	your	References.	
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5.9	Statistical	Analysis	
Where	statistical	analyses	have	been	carried	out	please	ensure	that	the	methodology	
has	been	accurately	described.	In	comparative	studies,	power	calculations	are	usually	
required.	In	research	papers,	requiring	complex	statistics,	the	advice	of	an	expert	
statistician	should	be	sought	at	the	design/implementation	stage	of	the	study.	
5.10	Peer	Review	
As	a	means	of	recognising	the	significant	contribution	reviewers	make	to	the	
publication	process	DIGITAL	HEALTH	aims	to	publish	the	names	of	the	reviewers	of	
accepted	articles	within	the	published	manuscript	itself.	The	publication	of	such	names	
is	dependent	on	both	parties	(authors	and	reviewers)	consenting	to	these	names	being	
published.	As	part	of	the	submission	process	you	will	be	asked	to	opt	in	or	out	of	having	
the	reviewers	names	published	within	your	paper.	
Back	to	top	
6.	Publishing	policies	
6.1	Publication	ethics	
SAGE	is	committed	to	upholding	the	integrity	of	the	academic	record.	We	encourage	
authors	to	refer	to	the	Committee	on	Publication	Ethics’	International	Standards	for	
Authors	and	view	the	Publication	Ethics	page	on	the	SAGE	Author	Gateway.	
6.1.1	Plagiarism	
DIGITAL	HEALTH	and	SAGE	take	issues	of	copyright	infringement,	plagiarism	or	other	
breaches	of	best	practice	in	publication	very	seriously.	We	seek	to	protect	the	rights	of	
our	authors	and	we	always	investigate	claims	of	plagiarism	or	misuse	of	published	
articles.	Equally,	we	seek	to	protect	the	reputation	of	the	journal	against	malpractice.	
Submitted	articles	may	be	checked	with	duplication-checking	software.	Where	an	
article,	for	example,	is	found	to	have	plagiarized	other	work	or	included	third-party	
copyright	material	without	permission	or	with	insufficient	acknowledgement,	or	where	
the	authorship	of	the	article	is	contested,	we	reserve	the	right	to	take	action	including,	
but	not	limited	to:	publishing	an	erratum	or	corrigendum	(correction);	retracting	the	
article;	taking	up	the	matter	with	the	head	of	department	or	dean	of	the	author's	
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institution	and/or	relevant	academic	bodies	or	societies;	or	taking	appropriate	legal	
action.	
6.1.2	Prior	publication	
If	material	has	been	previously	published,	it	is	not	generally	acceptable	for	publication	
in	a	SAGE	journal.	However,	there	are	certain	circumstances	where	previously	
published	material	can	be	considered	for	publication.	Please	refer	to	the	guidance	on	
the	SAGE	Author	Gateway	or	if	in	doubt,	contact	the	Editor	at	the	address	given	below.	
6.2	Contributor's	publishing	agreement	
Before	publication	SAGE	requires	the	author	as	the	rights	holder	to	sign	a	Journal	
Contributor’s	Publishing	Agreement.	DIGITAL	HEALTH	publishes	manuscripts	
under	Creative	Commons	licenses.	The	standard	license	for	the	journal	is	Creative	
Commons	by	Attribution	Non-Commercial	(CC	BY-NC),	which	allows	others	to	re-use	
the	work	without	permission	as	long	as	the	work	is	properly	referenced	and	the	use	is	
non-commercial.	For	more	information,	you	are	advised	to	visit	SAGE's	OA	licenses	
page.	
Alternative	license	arrangements	are	available,	for	example,	to	meet	particular	funder	
mandates,	made	at	the	author’s	request	(e.g.	CC-BY).	
Back	to	top	
7.	Preparing	your	manuscript	
• A	title	page	with	names	and	contact	details	for	all	authors	
• A	structured	abstract	
• The	text	(usually	Introduction,	Methods,	Results,	Discussion,	Conclusions)	
• Declarations	
• References	
• Appendix	(if	any)	
7.1	Journal	Styles	
DIGITAL	HEALTH	conforms	to	the	SAGE	house	style.	Click	here	to	review	guidelines	on	
SAGE	House	Style.	
 89 
7.2	Word	processing	formats	
The	preferred	format	for	your	manuscript	is	Word.	LaTeX	files	are	also	accepted.	Word	
and	(La)Tex	templates	are	available	on	the	Manuscript	Submission	Guidelines	page	of	
our	Author	Gateway.	
7.3	Corresponding	author	contact	details	
Provide	full	contact	details	for	the	corresponding	author	including	email,	mailing	
address	and	telephone	numbers.	Academic	affiliations	are	required	for	all	co-authors.	
These	details	should	be	presented	separately	to	the	main	text	of	the	article	to	facilitate	
anonymous	peer	review.	
You	will	be	asked	to	provide	contact	details	and	academic	affiliations	for	all	co-authors	
via	the	submission	system	and	identify	who	is	to	be	the	corresponding	author.	These	
details	must	match	what	appears	on	your	manuscript.	At	this	stage	please	ensure	you	
have	included	all	the	required	statements	and	declarations	and	uploaded	any	additional	
supplementary	files	(including	reporting	guidelines	where	relevant).	
7.4	Publication	of	Twitter	handles	
As	a	way	of	encouraging	ongoing	discussion	within	the	field,	DIGITAL	HEALTH	authors	
are	offered	the	option	of	providing	their	Twitter	handle	to	be	published	alongside	their	
name	and	email	address	within	their	article.	This	way	DIGITAL	HEALTH	readers	who	
have	questions	or	thoughts	regarding	your	paper	can	tweet	you	directly.	Providing	a	
Twitter	handle	for	publication	is	entirely	optional;	if	you	are	not	comfortable	
with	DIGITAL	HEALTH	promoting	your	article	along	with	your	personal	Twitter	handle	
then	please	do	not	supply	it.	
By	providing	your	personal	Twitter	handle	you	agree	to	let	DIGITAL	HEALTH	and	SAGE	
Publications	use	it	in	any	posts	related	to	your	journal	article.	You	may	also	be	
contacted	by	other	Twitter	users.	DIGITAL	HEALTH	and	SAGE	Publications	will	have	no	
control	over	you	or	your	tweets	at	any	time.	If	you	would	like	guidance	on	how	to	
promote	your	article	yourself	on	Twitter	or	other	Social	Media	channels	please	
visit	https://www.sagepub.com/increase-usage-citation-using-social-media.		
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To	include	your	Twitter	handle	within	your	article,	please	provide	this	within	the	SAGE	
Track	Submission	form	when	prompted,	on	the	manuscript	title	page	and	on	the	
manuscript	itself.	
Corresponding	author:	
Professor	Joe	Bloggs,	Department	of	Digital	Health,	University	of	Digital	Health,	Digital	
Health	Road,	
Digital	Health,	DHJ	2014,	UK	
Email:	JoeBloggs@email.com	
Twitter:	@profjoebloggs	
7.5	Artwork,	figures	and	other	graphics	
For	guidance	on	the	preparation	of	illustrations,	pictures	and	graphs	in	electronic	
format,	please	visit	SAGE’s	Manuscript	Submission	Guidelines.	
Photographic	illustrations	should	be	rendered	with	at	least	300	dpi;	please	use	CMYK	
color	conversion	if	possible.	Graphs	made	with	Office	software	such	as	Microsoft	Excel,	
can	be	provided	in	their	original	format	to	facilitate	conversion	into	printable	format	
with	preserved	quality.	Any	other	line	graphs/illustrations	should	preferably	be	
provided	in	EPS	format	with	a	resolution	of	at	least	600	dpi	to	prevent	ragged	lines	
when	printed.	A	figure	image	should	be	at	least	160	mm	in	width	at	the	appropriate	
resolution.	For	further	guidance	on	how	to	prepare	your	digital	image	
see	http://art.cadmus.com/da/index.jsp.	
Graphs	and	images	that	are	unsuitable	may	be	returned	to	the	author	for	amendment,	
causing	delay	in	publication.	
7.6	Units	of	measurement	
Units	of	measurement	should	be	expressed	in	SI	and	metric	units;	older	conventional	
units	may	be	added	in	parentheses.	
7.7	Nomenclature	
Use	the	generic	or	chemical	name	of	any	drug,	in	lower	case;	the	specific	trade	name	
(capitalized)	may	be	given	in	parentheses	after	the	first	text	reference.	
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7.8	Standard	abbreviations	and	symbols	
Standard	Abbreviations	and	symbols	should	be	used,	then	defined	in	full	in	the	first	
instance	unless	they	are	standard	units	of	measurement.	Avoid	any	use	of	abbreviations	
in	the	article	title	and	abstract.	
7.9	Supplementary	material	
This	journal	is	able	to	host	additional	materials	online	(e.g.	datasets,	podcasts,	videos,	
images	etc)	alongside	the	full-text	of	the	article.	These	will	be	subjected	to	peer-review	
alongside	the	article.	For	more	information	please	refer	to	our	guidelines	on	submitting	
supplementary	files,	which	can	be	found	within	our	Manuscript	Submission	
Guidelines	page.	
7.10	Guidelines	for	submitting	video	material	as	part	of	an	article	
Video	content	can	be	streamed	within	the	HTML	version	of	your	article.	If	you	would	
like	to	submit	a	video	as	part	of	your	article,	please	read	the	below	video	properties	
guidelines	carefully,	ensure	that	you	make	a	note	within	your	manuscript	as	to	where	
the	video	would	be	placed	and	upload	it	under	the	file	type	‘Additional	Video	Content’	
when	you	upload	your	manuscript	via	the	manuscript	submission	site.	
Please	note	that	an	audio-visual	release	form	for	each	individual	contributor	to	the	
video.	This	form	should	be	signed,	scanned	and	submitted	as	‘audio-visual	release	form’.	
The	form	is	located	here.	
Video	Properties:	
• 	
o At	least	640	by	480	resolution	and	at	least	20	fps.	
o The	video	compression	should	be	of	high	quality.	The	Journal	expects	
compression	technology	to	evolve	and	so	does	not	wish	to	be	prescriptive	
over	compression	types.	Today	H.264	codec	in	an	MP4	or	AVI	contained	is	
a	good	choice.		MPEG-1	and	MPEG-2	are	portable	but	have	lower	quality	
and	larger	files	than	the	more	modern	codecs.	We	expect	videos	to	be	able	
to	play	on	Windows	8	and	back,	Linux	and	Mac	so	proprietry	formats,	
such	as	WMV	and	FLV	are	discouraged.	
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o Note	the	DIGITAL	HEALTH	Editors-in-Chief	reserve	the	right	to	request	
authors	to	change	the	compression	codec	before	publication.	
Videos	should	be	below	the	50MB	mark	and	any	video	over	this	amount	should	provide	
a	short	preview	to	be	hosted	alongside	the	full	file.	Exceptions	may	be	made	at	the	
discretion	of	the	Editors-in-Chief.	
7.11	Guidelines	for	submitting	a	video	abstract	(Vidab)	
A	video	abstract	is	a	short	video	introduction	to	your	article,	which	can	be	linked	to	
from	the	Table	of	Contents	on	SAGE	Journals,	promoted	via	Social	Media,	and	shared	
directly	by	you	with	your	own	networks.	It	is	intended	to	be	an	addition	to,	rather	than	
replacement	of,	your	text	abstract.	
For	further	information	regarding	video	abstracts	please	see	the	SAGE	Video	
guidelines:	Video	Abstract	Guidelines.	
Please	note	that	an	audio-visual	release	form	for	each	individual	contributor	to	the	
Vidab.	This	form	should	be	signed,	scanned	and	submitted	as	‘audio-visual	release	
form’.	The	form	is	located	here.	
7.12	Reference	style	
DIGITAL	HEALTH	adheres	to	the	SAGE	Vancouver	reference	style.	Please	review	
the	guidelines	on	SAGE	Vancouver	to	ensure	your	manuscript	conforms	to	this	
reference	style.	
If	you	use	EndNote	to	manage	references,	you	can	download	the	SAGE	Vancouver	
output	file	here.	
7.13	English	language	editing	services	
Authors	seeking	assistance	with	English	language	editing,	translation,	or	figure	and	
manuscript	formatting	to	fit	the	journal’s	specifications	should	consider	using	SAGE	
Language	Services.	Visit	SAGE	Language	Services	on	our	Journal	Author	Gateway	for	
further	information.	
Back	to	top	
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8.	Submitting	your	manuscript	
8.1	How	to	submit	your	manuscript	
DIGITAL	HEALTH	is	hosted	on	SAGE	Track,	a	web	based	online	submission	and	peer	
review	system	powered	by	ScholarOne™	Manuscripts.	
Visit	http://mc.manuscriptcentral.com/dhj	to	login	and	submit	your	article	online.	
IMPORTANT:	Please	check	whether	you	already	have	an	account	in	the	system	before	
trying	to	create	a	new	one.	If	you	have	reviewed	or	authored	for	the	journal	in	the	past	
year	it	is	likely	that	you	will	have	had	an	account	created.		For	further	guidance	on	
submitting	your	manuscript	online	please	visit	ScholarOne	Online	Help.	
All	papers	must	be	submitted	via	the	online	system.	If	you	would	like	to	discuss	your	
paper	prior	to	submission,	please	refer	to	the	contact	details	below.	
Please	note	that,	in	addition	to	selecting	your	article	type,	you	will	also	be	asked	to	
select	the	primary	discipline	that	you	believe	best	matches	your	paper	from	the	
following	list:	
Clinical	Applications	and	Trials	
Engineering,	Technology	and	Health	Care	
Social	Sciences,	Public	Health	and	Health	Care	
This	information	will	be	used	to	select	the	Editor-in-Chief	who	is	best	placed	to	process	
your	manuscript.	Given	the	multi-disciplinary	nature	of	DIGITAL	HEALTH	content,	there	
will	be	instances	where	more	than	one	Editor-in-Chief	is	involved	in	deciding	the	final	
outcome	of	a	paper.	The	Editorial	Office	reserves	the	right	to	transfer	your	paper	to	
another	primary	discipline	for	processing.	
If	you	seek	advice	on	the	submission	process,	please	contact	the	Editorial	Office	
at:	digitalhealth@sagepub.co.uk.	
8.2	Title,	keywords	and	abstracts	
Please	supply	a	title,	short	title,	an	abstract	and	keywords	to	accompany	your	article.	
The	title,	keywords	and	abstract	are	key	to	ensuring	readers	find	your	article	online	
through	online	search	engines	such	as	Google.	Please	refer	to	the	information	and	
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guidance	on	how	best	to	title	your	article,	write	your	abstract	and	select	your	keywords	
by	visiting	the	SAGE	Journal	Author	Gateway	for	guidelines	on	How	to	Help	Readers	
Find	Your	Article	Online.	
Keywords:	2-10	to	accompany	the	abstract.	They	should,	where	relevant,	be	drawn	
from	the	MeSH	list	of	Index	Medicus	and	be	chosen	with	a	view	to	useful	cross-indexing	
of	the	article.	
Abstract:	The	abstract	should	accurately	and	concisely	reflect	the	content	of	the	article,	
and	should	be	limited	to	250	words	for	text	articles	and	500	words	for	audio-visual	
content.	Please	avoid	reference	citations	and	undefined	abbreviations	in	the	abstract.	
Where	applicable	the	abstract	should	be	formatted	under	the	following	headings:	
Objective,	Methods,	Results,	Conclusions.	
8.3	Informtion	required	for	completing	your	submission	
Provide	full	contact	details	for	the	corresponding	author	including	email,	mailing	
address	and	telephone	numbers.	Academic	affiliations	are	required	for	all	co-authors.	
These	details	should	be	presented	separately	to	the	main	text	of	the	article	to	facilitate	
anonymous	peer	review.	
You	will	be	asked	to	provide	contact	details	and	academic	affiliations	for	all	co-authors	
via	the	submission	system	and	identify	who	is	to	be	the	corresponding	author.	These	
details	must	match	what	appears	on	your	manuscript.	At	this	stage	please	ensure	you	
have	included	all	the	required	statements	and	declarations	and	uploaded	any	additional	
supplementary	files	(including	reporting	guidelines	where	relevant).	
	
	
	
